According to an expert consensus document on acromegaly therapeutic outcomes, GH nadir levels <1 μg/L after glucose load reflect cure following surgical intervention, with evidence to support GH suppression is associated with improved long-term outcomes and reduced mortality. The gene discussed is GH1; the disease is acromegaly.